Multiple endocrine neoplasia type I, commonly referred to as MEN I, is a rare genetic disorder that affects the endocrine system. It is characterized by the development of tumors in multiple glands of the endocrine system, including the parathyroid, pituitary, and pancreas.
MEN I is an autosomal dominant disorder, which means that if one parent carries the mutated gene, there is a 50% chance of their children inheriting the condition. The disease is caused by a mutation in the MEN1 gene, which provides instructions for making a protein called menin. This protein acts as a tumor suppressor, preventing the growth of tumors in the endocrine system.
MEN I is typically diagnosed through genetic testing or through imaging studies that reveal the presence of tumors. Treatment for MEN I varies depending on the specific tumors and their severity, but may include surgery, medication, or radiation therapy. Regular monitoring and screening for tumors is also important for individuals with MEN I.
In summary, MEN I is a rare genetic disorder that affects the endocrine system and can cause tumors in multiple glands, including the parathyroid, pituitary, and pancreas. It is caused by a mutation in the MEN1 gene and is typically diagnosed through genetic testing or imaging studies. Treatment varies depending on the specific tumors and may include surgery, medication, or radiation therapy.
Multiple Endocrine Neoplasia Type I (MEN 1) is a rare genetic disorder that affects the endocrine system. It causes tumors to grow in multiple glands of the body, resulting in overproduction of hormones. This can lead to various health problems, including high blood pressure, kidney stones, and diabetes.
While t...
To see full information about treatment please Sign up or Log in